» Articles » PMID: 39820667

A Lambda-evo (λ) Phage Platform for Zika Virus E Protein Display

Abstract

One of the most significant bacteriophage technologies is phage display, in which heterologous peptides are exhibited on the virion surface. This work describes the display of λ decorative protein D linked to the E protein domain III of Zika virus (D-ZE), to the GFP protein (D-GFP), or to different domain III epitopes of the E protein (D-TD), exhibited on the surface of an in vitro evolved lambda phage (λ). This phage harbors a gene D deletion and was subjected to directed evolution using Escherichia coli W3110/pD-ZE as background. After 20 days (20 cycles of dilution), the λ phage developed a ~ 22% genome deletion affecting the non-essential λ b region, rendering a more stable phage that exhibited fusion proteins D-ZE or D-GFP but not D-TD. Despite the λ system was able to decorate itself with the D-ZE protein, the production of viral particles was ~ 1000-fold lower than the λ wild-type, due to the unexpected D-ZE protein aggregation into bacterial inclusion bodies. Decorated phages (10 PFU (plaque forming units)/100 µl) were inoculated into BALB/c mice, and subsequent dot blot and Western blot immunoassays proved the production of murine antibodies against ZIKV (Zika virus). This multipurpose λ phage display platform may be used interchangeably with other more soluble peptides, providing better yields. KEY POINTS: • λ platform for displaying recombinant peptides. • Directed evolution to generate λ with more efficient decoration. • Antigenic reaction in BALB/c mice by inoculating λ with recombinant peptides.

References
1.
Thomas B, Nishikawa S, Ito K, Chopra P, Sharma N, Evans D . Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccine. Vaccine. 2012; 30(6):998-1008. DOI: 10.1016/j.vaccine.2011.12.070. View

2.
Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M . Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006; 2:2006.0008. PMC: 1681482. DOI: 10.1038/msb4100050. View

3.
Nishimura Y, Yoshida T, Kuronishi M, Uehara H, Ogata H, Goto S . ViPTree: the viral proteomic tree server. Bioinformatics. 2017; 33(15):2379-2380. DOI: 10.1093/bioinformatics/btx157. View

4.
van Belleghem J, Merabishvili M, Vergauwen B, Lavigne R, Vaneechoutte M . A comparative study of different strategies for removal of endotoxins from bacteriophage preparations. J Microbiol Methods. 2016; 132:153-159. DOI: 10.1016/j.mimet.2016.11.020. View

5.
Barati N, Razazan A, Nicastro J, Slavcev R, Arab A, Mosaffa F . Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice. Cancer Lett. 2018; 424:109-116. DOI: 10.1016/j.canlet.2018.03.030. View